
Roundtable Q&A: The Future of KOL/KEE ID and Mapping
The BioPharma world is a fast-evolving one, but Key Opinion Leaders (KOLs) and Key External Experts (KEEs) remain the core component of transforming awareness into action. What is KOL/KEE Identification and what are some scenarios in which it might be done? KOL/KEE Identification and mapping is pinpointing highly respected, distinguished,

BioPharma Trends in the News – October 2025
The BioPharma industry is in rapid flux, shaped by rising tariffs, shifting policies, and new barriers to prescription access. Here’s a quick look at the forces driving change. Source: Reuters Several major pharmaceutical companies are responding to recent U.S. policy shifts by cutting drug prices and announcing plans to sell

Giving Back Together: V2V Omaha Office Volunteers at Food Bank for the Heartland
At Vision2Voice, we believe that meaningful connections extend beyond the work we do for our clients—they’re built through service to our communities as well. Recently, our Omaha team spent the morning volunteering at Food Bank for the Heartland. The foodbank is a nonprofit organization headquartered in Omaha that ensures consistent access
How to Identify Top Experts
Discover proven strategies for selecting the right engagement tools for pharmaceutical Virtual Speaker Programs to create memorable peer-to-peer learning experiences that drive results.

BioPharma Trends in the News – September 2025
The BioPharma industry is in rapid flux, shaped by rising tariffs, shifting policies, and new barriers to prescription access. Here’s a quick look at the forces driving change. Source: Time.com The time is now to review your campaigns as FDA oversight ramps up after years of minimal enforcement. Trump’s executive
3 Hidden Traps to Avoid with Congress Management
Discover proven strategies for selecting the right engagement tools for pharmaceutical Virtual Speaker Programs to create memorable peer-to-peer learning experiences that drive results.
BioPharma Trends in the News – August 2025
Source: FiercePharma President Donald Trump is pressing ahead with plans to impose steep tariffs on imported pharmaceuticals—starting small but ramping up to 250%—in a bid to push drug manufacturing back to the U.S. The move, paired with a revived “most favored nation” pricing policy, has already spurred major pharma companies
Are Your Speaker Programs Ready for the New Sunshine Act Standards? 3 Key Considerations
Discover proven strategies for selecting the right engagement tools for pharmaceutical Virtual Speaker Programs to create memorable peer-to-peer learning experiences that drive results.